Spirometry
Spirometry has been studied in 4 papers since 2018: 4 observational studies in people; 1 in the past year. The newest paper, Mar 3, 2026: “Integrating Lung Function Parameters into the Framingham Score for Improved CVD Risk Prediction in COPD: A Cross-Sectional Study Based on NHANES 2007-2012”.
See all 4 papers on spirometry
At a glance
The findings reach people, from one lab or study. 2 independent labs in 3 countries.
“People who received spirometry at treatment initiation had a 34% lower mortality risk (adjusted hazard ratio, 0.66; 95% CI, 0.63-0.70)”
None of its findings points the other way.
- 2 independent labs in 3 countries
- Funders: Australian Government and 1 more
- 2 of 3 findings with company ties
- Humans4
What did studies of spirometry find?
2Studies of spirometry measured 2 outcomes; the most studied are Predictive discrimination (1 study) and bronchodilators (1).
Predictive discrimination
upin humans1
1 study
Predictive discrimination
upin humans1
Spirometry is linked with better predictive discrimination in individuals with COPD (AUC 0.724 vs 0.646, p < 0.01).
“The integration of lung function parameters with the Framingham Risk Score (FRS) improved predictive discrimination.”
Humansin individuals with COPD
COPD
Bronchodilators
downin humans1
1 study
Bronchodilators
downin humans1
Spirometry is linked with lower bronchodilators in humans (at chronic respiratory medication initiation).
“People who received spirometry at treatment initiation had a 34% lower mortality risk (adjusted hazard ratio, 0.66; 95% CI, 0.63-0.70) and had less use of short-acting bronchodilators.”
Humansat chronic respiratory medication initiationn = 146,205
Chest
What is spirometry linked with?
1Studies link spirometry with 1 measure, most often mortality (1 study).
Mortality
downin humans1
1 study
Mortality
downin humans1
Spirometry is linked with a lower risk of mortality in humans (at chronic respiratory medication initiation) (34% lower risk, aHR 0.66, 95% CI 0.63-0.70).
“People who received spirometry at treatment initiation had a 34% lower mortality risk (adjusted hazard ratio, 0.66; 95% CI, 0.63-0.70)”
Humansat chronic respiratory medication initiationn = 146,205
Chest